Showing results (11-20 of 109) with videos related to
Sort By:
Pageof 11
Frontiers in Neurology|November 8, 2023
Machine learning-based radiomics to differentiate immune-mediated necrotizing myopathy from limb-girdle muscular dystrophy R2 using MRIPing Wei, Huahua Zhong, Qian Xie, et al.Frontiers in Neurology|December 9, 2021
Comorbid Autoimmune Diseases in Patients With Myasthenia Gravis: A Retrospective Cross-Sectional Study of a Chinese CohortJianquan Shi, Xiao Huan, Lei Zhou, et al.Expert Opinion on Biological Therapy|May 20, 2026
Real-world implications of efgartigimod in managing refractory myasthenia gravisDingxian He, Nayuan Hu, Chong Yan, et al.European Journal of Neurology|March 13, 2026
Who Can Safely Discontinue Treatment in Myasthenia Gravis? Insights From a Long-Term Real-World StudyDingxian He, Chong Yan, Baitong Wang, et al.Intensive Care Medicine|September 10, 2024
Complement system activation: bridging physiology, pathophysiology, and therapyElie Azoulay, Julien Zuber, Ahmed Aziz Bousfiha, et al.Frontiers in Neurology|July 18, 2022
Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After ImmunotherapyYan Wang, Chong Yan, Caixia Su, et al.Frontiers in Immunology|February 14, 2022
A Targeted Complement Inhibitor CRIg/FH Protects Against Experimental Autoimmune Myasthenia Gravis in Rats <i>via</i> Immune ModulationJie Song, Rui Zhao, Chong Yan, et al.Brain : a Journal of Neurology|October 29, 2024
AAV-based TCAP delivery rescues mitochondria dislocation in limb-girdle muscular dystrophy R7Xiaoqing Lv, Shuangwu Liu, Xi Li, et al.Journal of the Peripheral Nervous System : JPNS|January 13, 2025
Ofatumumab for treating autoimmune nodopathyJianian Hu, Yongsheng Zheng, Chong Sun, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 8, 2020
Congenital myasthenia syndrome in a Chinese family with mutations in MUSK: A hotspot mutation and literature reviewYiqi Liu, Kai Qiao, Chong Yan, et al.Pageof 11